Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.
Inclusion Criteria:

 -  Diagnosis of asthma

 -  Patients treated with inhaled corticosteroid and long acting beta 2 agonist

 -  FEV1(forced expiratory volume in 1 second)>50% to 80%

 Exclusion Criteria:

 -  Respiratory infection within 2weeks

 -  Asthma exacerbation within 6 weeks